IL-6 Protects enterocytes from hypoxia-induced apoptosis by induction of bcl-2 mRNA and reduction of fas mRNA

Biochemical and Biophysical Research Communications

Volumn 347, Issue 4, 2006, Pages 1094-1098

  Rollwagen, F M ^a   Madhavan, S ^a,b   Singh, A ^a   Li, Y Y ^c   Wolcott, K ^a   Maheshwari, R ^a  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b BIRLA INSTITUTE OF TECHNOLOGY AND SCIENCE   (India)

^c HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE   (United States)

Author keywords

IL 6; Intestinal epithelial cells; Tissue culture

Indexed keywords

FAS ANTIGEN; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; PROTEIN BCL 2;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CULTURE; CELL PROTECTION; COCULTURE; CONTROLLED STUDY; GENE INDUCTION; HYPOXIA; HYPOXIC CELL; INTESTINE EPITHELIUM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REDUCTION; RIBONUCLEASE PROTECTION ASSAY;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; CELL HYPOXIA; CELL LINE; ENTEROCYTES; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RECEPTORS, INTERLEUKIN-6; RNA, MESSENGER;

EID: 33746349841     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.07.016     Document Type: Article

References (24)

1. Rollwagen F.M., and Baqar S. Oral administration of cytokines. Immunol. Today 17 (1996) 548-550
2. Rollwagen F.M., Li Y.-Y., Pacheco N.D., and Baqar S. Systemic sepsis following hemorrhagic shock: alleviation with oral Interleukin-6. Mil. Med. 162 (1997) 366-370
3. Rollwagen F.M., Li Y.-Y., Pacheco N.D., and Nielsen T.B. Systemic bacteraemia following haemorrhage in mice: alleviation with oral Interleukin-6. Cytokine 8 (1996) 121-129
4. Rollwagen F.M., Li Y.-Y., Pacheco N.D., Dick E.J., and Kang Y.-H. Microvascular effects of oral interleukin-6 in the murine small intestine. Am. J. Pathol. 156 (2000) 1177-1182
5. Shirota K., LeDuy L., Yuan S., and Jothy S. Interleukin-6 and its receptor are expressed in human intestinal epithelial cells. Virchows Arch. 58 (1990) 303-308
6. Molmenti E.P., Ziambaras T., and Perlmutter D.H. Evidence for an acute phase response in human intestinal epithelial cells. J. Biol. Chem. 268 (1993) 14116-14124
7. Wang L., Walia B., Evans J., Gewirtz A.T., Merlin D., and Sitaraman S.V. IL-6 induces NF-κB activation in the intestinal epithelia. J. Immunol. 171 (2003) 3194-3201
8. Panja A., Siden E., and Mayer L. Synthesis and regulation of accessory/proinflammatory cytokines by intestinal epithelial cells. Clin. Exp. Immunol. 100 (1995) 298-305
9. Rollwagen F.M., Yu Z.-Y., Li Y.-Y., and Pacheco N.D. IL-6 rescues enterocytes from hemorrhage induced apoptosis in vivo and in vitro by a bcl-2 mediated mechanism. Clin. Immunol. Immunopathol. 89 (1998) 205-213
10. Rollwagen F.M., Davis T.A., Li Y.-Y., Pacheco N.D., and Zhu X.-L.-. Mobilization of CFU-GM progenitor cells and elevation of GM-CSF gene expression following oral administration of IL-6. Cytokine 27 (2004) 107-112
11. Kimizuka K., Nakao A., Nalesnik M.A., Demetris A.J., Uchiyama T., Ruppert K., Fink M.P., Solz D.B., and Murase N. Exogenous IL-6 inhibits acute inflammatory responses and prevents ischemia/reperfusion injury after intestinal transplantation. Am. J. Transplant. 4 (2004) 482-494
12. Brod S.A. Ingested type I interferon: state of the art as treatment for autoimmunity. Exp. Biol. Med. (Maywood) 227 (2002) 981-988
13. Cummins J.M., Beilharz M.W., and Krakowka S. Oral use of interferon. J. Interferon Cytokine Res. 19 (1999) 853-857
14. Cummins J.M., Tompkins M.B., Olsen R.G., Tompkins S.A., and Lewis M.G. Oral use of human alpha interferon in cats. J. Biol. Resp. Mod. 7 (1998) 513-523
15. Bedrin M.S., Abolafia C.M., and Thompson J.F. Cytoskeletal association of epidermal growth factor receptor and associated signaling proteins is regulated by cell density in IEC-6 intestinal cells. J. Cell Physiol. 172 (1997) 126-136
16. Mariadason J.M., Rickard K.L., Barkla D.H., Augenlicht L.H., and Gibson P.R. Divergent phenotypic patterns and commitment to apoptosis of Caco-2 cells during spontaneous and butyrate-induced differentiation. J. Cell Physiol. 183 (2000) 347-354
17. Kijima K., Matsubara H., Murasawa S., Maruyama K., Ohkubo N., Mori Y., and Inada M.M. Regulation of angiotensin II type 2 receptor gene by the protein kinase C-calcium pathway. Hypertension 27 (1996) 529-534
18. de Filippis V., Polverino de Laurento P., Toniutti N., and Fontana A. Acid-induced molten globule state of a fully active mutant of human Interleukin-6. Biochemistry 35 (1996) 11503-11511
19. Kolvenbach C.G., Narhi L.O., Philo J.S., Li T., Zhang M., and Arakawa T. Granulocyte-colony stimulating factor maintains a thermally stable, compact, partially folded structure at pH2. J. Pept. Res. 50 (1997) 310-318
20. Husain K.D., Stromberg P.E., Javadi P., Buchanan T.G., Karl I.E., Hotchkiss R.S., and Coopersmith C.M. Bcl-2 inhibits gut epithelial apoptosis induced by acute lung injury in mice but has no effect on survival. Shock 20 (2003) 437-443
21. Leu C.M., Wong F.H., Chang C., Huang S.F., and Hu C.P. Interleukin-6 acts as an antiapoptotic factor in human esophageal carcinoma cells through the activation of both STAT3 and mitogen-activated protein kinase pathways. Oncogene 22 (2003) 7809-7818
22. Schumann R.R., Belka C., Reuter D., Lamping N., Kirschning C.J., Weber J.R., and Pfiel D. Lipopolysaccharide activates caspase-1 (Interleukin-1-converting-enzyme) in cultured monocytic and endothelial cells. Blood 91 (1998) 577-584
23. Hong F., Kim W.H., Tian Z., Jaruga B., Ishac E., Shen X., and Gao B. Elevated interleukin-6 during ethanol consumption acts as a potential endogenous protective cytokine against ethanol-induced apoptosis in the liver: involvement of induction of Bcl-2 and Bcl-x(L) proteins. Oncogene 21 (2002) 32-43
24. Kovalovich K., Wei L., DeAngelis R., Greenbaum L.E., Ciliberto G., and Taub R. Interleukin-6 protects against Fas-mediated death by establishing a critical level of anti-apoptotic hepatic proteins FLIP, Bcl-2, and Bcl-xL. J. Biol. Chem. 276 (2001) 26605-26613